The associations between HMOX1 promoter polymorphisms and clinical outcomes were also observed among patients with other forms of kidney disease, such as renal transplantation, diabetic kidney disease and sickle cell nephropathy [125,126,127]. This evidence concerns the gene HMOX1 and kidney disorder.